TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3029% below fair value
$91.38−0.62 (-0.67%)
Close on Nov 13, 2026Market cap $3.17BP/E 25.0Yield 0.00%
TransMedics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
TransMedics's ebitda for the twelve months ending Sep 30, 2026 was $126.86M, up 4.5% year over year. For fiscal 2025 it was $135.77M, up 137.1% from the year before. The highest annual figure on record is $135.77M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.77M | +137.1% |
| FY2024 | Dec 31, 2024 | $57.25M | – |
| FY2023 | Dec 31, 2023 | -$20.55M | – |
| FY2022 | Dec 31, 2022 | -$27.96M | – |
| FY2021 | Dec 31, 2021 | -$37.61M | – |
| FY2020 | Dec 31, 2020 | -$24.81M | – |
| FY2019 | Dec 28, 2019 | -$28.38M | – |
| FY2018 | Dec 29, 2018 | -$19.47M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $38.98M | +29.3% |
| Q2 FY2026 | Jun 30, 2026 | $33.98M | -21.5% |
| Q1 FY2026 | Mar 31, 2026 | $25.16M | -25.1% |
| Q4 FY2025 | Dec 31, 2025 | $28.74M | +100.6% |
| Q3 FY2025 | Sep 30, 2025 | $30.15M | +231.3% |
| Q2 FY2025 | Jun 30, 2025 | $43.30M | +153.1% |
| Q1 FY2025 | Mar 31, 2025 | $33.58M | +100.8% |
| Q4 FY2024 | Dec 31, 2024 | $14.32M | +130.7% |
| Q3 FY2024 | Sep 30, 2024 | $9.10M | – |
| Q2 FY2024 | Jun 30, 2024 | $17.11M | +3420.0% |
| Q1 FY2024 | Mar 31, 2024 | $16.72M | – |
| Q4 FY2023 | Dec 31, 2023 | $6.21M | – |
| Q3 FY2023 | Sep 30, 2023 | -$26.44M | – |
| Q2 FY2023 | Jun 30, 2023 | $486.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$802.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.65M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.95M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.86M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.86M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.42M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.06M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.47M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.21M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.49M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.65M | – |
| Q4 FY2019 | Dec 28, 2019 | -$8.34M | – |
| Q3 FY2019 | Sep 28, 2019 | -$6.91M | – |
| Q2 FY2019 | Jun 29, 2019 | -$7.42M | – |
| Q1 FY2019 | Mar 30, 2019 | -$5.72M | – |
| Q4 FY2018 | Dec 29, 2018 | -$6.14M | – |
| Q3 FY2018 | Sep 29, 2018 | -$3.73M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.99M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.62M | – |
See a number that looks wrong?